SAN DIEGO -- A novel therapy for polycythemia vera (PCV) maintained stable hematocrit levels for as long as 2.5 years and significantly reduced use of phlebotomy, a small randomized trial showed. The ...

Please provide your email address to receive an email when new articles are posted on . High hematocrit levels were observed among 8.4% of adults receiving gender-confirming testosterone therapy.

Credit: Thinkstock. The risk of hematocrit elevation may depend on testosterone therapy's route of administration, according to investigators. A rise in hematocrit levels occurs with 4 months of ...

ATLANTA -- Maintaining patients with polycythemia vera at hematocrit levels below 45% reduced thrombotic complications without increasing rates of other serious adverse events compared with a higher ...

Please provide your email address to receive an email when new articles are posted on . ATLANTA — The standard approach of maintaining hematocrit levels less than 45% in patients with polycythemia ...

Why it matters: Hematocrit reflects your red blood cell count, crucial for oxygen transport and overall health. Low levels can signal anemia or other health issues. Common causes: Iron deficiency, ...

Ruxolitinib improved hematocrit and white blood cell levels in PV patients, showing superiority over hydroxyurea and reducing phlebotomy frequency. In cGVHD patients, ruxolitinib reduced ...

The use of testosterone as gender-affirming hormone therapy (GAHT) among transgender men is associated with a lower risk for erythrocytosis (abnormal blood cell elevation) than was previously reported ...

Atlanta, GA - Maintaining a lower hematocrit (HCT) can help reduce the risk of cardiovascular death in patients with polycythemia vera, according to the results of CYTO-PV [1]. Those who had an HCT of ...